Cancer Stem Cells
-
Upload
amudhavaani-karunanidhi -
Category
Documents
-
view
11 -
download
0
description
Transcript of Cancer Stem Cells
![Page 1: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/1.jpg)
“Cancer Stem Cells”
CAMB 512
February 21, 2008
![Page 2: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/2.jpg)
What makes a stem cell a stem cell?
1. Self-renewal - when a stem cell divides, each daughter cell can either retain its stem cell identity, or can become a progenitor. Stem cells appear to retain capacity for limitless division.
2. Multipotency - progenitors (also called transit amplifying cells) have limited proliferative capacity and are committed to terminally differentiate into multiple lineages (multipotent). Often have high proliferative rates in the short term, whereas most stem cells divide rarely.
Progenitor cell
Stem cell
A B C D
Different cell types…
![Page 3: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/3.jpg)
Embryonic stem cells derived from blastocysts - E3.5 mouse embryos
Pluripotent (able to contribute to all embryonic tissues in vivo)
Can be primed to differentiate into an increasing number of cell types in vitro
Human ES cell lines…technical, ethical, oversight issues abound
![Page 4: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/4.jpg)
Paradigm - hematopoietic stem cells (HSCs) - found in bone marrow in adults (yolk sac blood islands, AGM, and fetal liver in developing embryos).
Self-renew and are multipotent - but, very few in number, hard to identify. How can we study in the laboratory…?
Bone marrow biopsy
What are the criteria by which stem cells can be identified?
![Page 5: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/5.jpg)
Adoptive transfer…the idea behind Bone Marrow Transplant in patients
One can also separate marrow cells by virtue of the cell-surface proteins they express by fluorescence activated cell sorting (FACS)
By testing these separated cells, identified some that produce long-term (ie, permanent) reconstitution of all blood cell lineages in recipient mice - at least some of these are stem cells. Short-term reconstitution characteristic of progenitor cells.
LTR cells express specific markers, pump out rhodamine or Hoescht dyes through ABC transporters (“side-population” cells).
Very few cells (~1/10,000) in bone marrow have LTR stem cell properties…
![Page 6: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/6.jpg)
Current view of hematopoietic differentiation from HSC - gradual process of restricting fate. CSFs and lineage-specific transcription factors, drive
expression of critical genes
![Page 7: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/7.jpg)
Criteria for identifying adult stem cells - need for caution…
Self-renewal and pluripotency - require relevant assays!!
Cell purification - ideally, single cell resolution (markers).
Single LacZ+ Lin-
CD29hiCD24+ cell repopulates a mammary fat pad.
Shackleton et. al, (2006) Nature 439: 84-88
![Page 8: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/8.jpg)
Huntly and Gilliland (2005) NRC 5: 311-321
Recognized fairly recently that a subset of cancer cells seem capable of self-renewing and producing tumors either in vitro or in vivo.
1994 - first real identification of a true “cancer stem cell” (AML), which can repeatedly confer disease in recipient mice.
How do stem cells relate to cancer?
![Page 9: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/9.jpg)
John Dick:Leukemia Initiating cell: CD34+CD38- 1/250,000 AML cells
NOT: CD34+CD38+
CD34-CD38-
Lapidot et al. (1994) Nature 367:645-648.
Cells initiating acute myeloid leukemia after transplantation into SCID mice
![Page 10: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/10.jpg)
Human AML originates from primitive HSCs?(but frequency varies)
Bonet and Dick (1997) Nat. Med. 3:730-737
![Page 11: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/11.jpg)
![Page 12: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/12.jpg)
Model for normal and AML hematopoietic system
![Page 13: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/13.jpg)
Cells from 9 breast cancer patients (pleural effusion) either purified directly (UP) or passaged once in mice (P)
Based on previous work looking at cell surface markers on breast ca cells, authors purified a subpopulation of tumor cells that express high levels of CD44 expression, low levels of CD24, etc.
ONLY these CD44+, CD24-/low cells (~15% of total) reproducibly formed tumors when injected into the mammary pads of immunodeficient mice. Other cells did NOT form new tumors, even when 10 X more cells were injected (exception - T7).
Consistent with idea of cancer stem cells…
Non-hematopoietic cancer stem cells…
Al-Hajj et. al (2003) PNAS 100: 3983-3988
![Page 14: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/14.jpg)
Would you have any concerns about this approach…?
Histology from the injection site
![Page 15: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/15.jpg)
Dick (2003) PNAS 100:3547-3549
![Page 16: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/16.jpg)
![Page 17: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/17.jpg)
Where would a cancer stem cell come from? Transformation of normal SC?
Alternative - “dedifferentiation” of a committed progenitor through which it gains ability to self-renew. Recent evidence strongly supports this idea…
In either case, multiple additional mutations are almost certainly needed to create full-blown cancer stem cell…
Progeny of CSC aren’t normal, but have limited proliferative potential (similar to normal progenitors).
Pardal, Clarke, Morrison NRC 2003
![Page 18: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/18.jpg)
August 2006 - report in Cell that fibroblasts can be converted into “embryonic stem”-like cells when engineered to express only four specific genes!! (not really true ES cells…but pretty close!)
So, aspects of “stem-ness” can be conferred on differentiated cells with minimal genetic changes! Implications for cancer stem cells are huge...
Takahashi and Yamanaka 2006 Cell 126: 1-14
![Page 19: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/19.jpg)
Fibroblasts engineered to express only four specific genes - Oct-4, c-Myc, Sox2 and KLF4, can be converted into cells indistinguishable from bona fide ES cells. These iPS (induced pluripotent cells) can generate live-born mice!
Demonstrates that true “stem-ness” can be conferred on non-stem cells…
From Wernig et. al (2007) Nature 448: 318-325
See also Okita et. al, (2007) Nature 448: 313-17Maherali et. al (2007) Cell Stem Cell 1: 55-70
![Page 20: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/20.jpg)
Also 2006, Scott Armstrong’s group* (HMS) showed that if they introduced a specific leukemic translocation (MLL-AF9) into committed progenitor cells (GMPs), and then injected these transformed cells into mice - they get cancer (AML)! Called cells that cause this leukemia “L-GMPs”.
But - the disease is transferable to new mice - hence, gained self-renewal… 1/6 cells by limiting dilution. Culturing cells in differentiation medium reduces the number of L-GMPs - so they can also differentiate into other cells...
*Krivtsov et. al (2006) Nature 442:818-822
![Page 21: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/21.jpg)
Self-renewal correlates to changes in gene expression - 363 genes altered in the self-renewing L-GMPs compared to initial GMPs. 91 of those 363 genes have been linked to self-renewal in other stem cells.
Implication - one transforming event (in this case, the MLL-AF9 transgene) may produce conditions that allow for selection of a self-renewal program...
Details will differ for different tissues, but - it may not require a large number of genetic changes to make a tumor initiating cell…
Time will tell -
![Page 22: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/22.jpg)
•AML (acute myeloid leukemia)•medulloblastomas•glioblastomas•colon cancer•ALL (acute lymphoblastic leukemia)
Cancer Stem Cells Identified in Human Cancers:
![Page 23: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/23.jpg)
Identification of human CD133+ brain tumor initiating cells
Singh et al. (2004) Nature 432:396-401
![Page 24: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/24.jpg)
100 CD133+ cells sufficient to induce medulloblastoma in mice; 105 CD133- insufficient
![Page 25: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/25.jpg)
O’Brien et al. (2007) Nature 445:106-110
Human colon cancer cells initiating tumors in SCID mice
“CC-ICs” are CD133+
![Page 26: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/26.jpg)
Limiting Dilution Analysis
![Page 27: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/27.jpg)
Ricci-Vitiani et al. (2007) 445:11-115
Rare CD133+ cells in colon cancer
![Page 28: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/28.jpg)
![Page 29: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/29.jpg)
The big question - what’s different about cancer SCs (or tumor-initiating cells - TICs) from normal SCs?
Traditional therapies may be best at “debulking” majority of cancer cells in tumors, but may be less effective at eradicating cancer SCs…also, SCs are particularly resistant to many chemotherapeutics (ABC transporters, etc.) - “side population” cells particularly good at pumping out drugs, making them resistant…obvious problem!
Multi-drug resistance (MDR)
![Page 30: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/30.jpg)
Are we targeting the right cancer cells….?!?
If we could target cancer SCs, what about your skin, blood, gut lining, etc.? How selective could we be?
Huntly and Gilliland (2005) NRC 5:311
![Page 31: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/31.jpg)
Rich (2007) Cancer Res. 67:8980-8984
![Page 32: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/32.jpg)
QuickTime™ and aTIFF (Uncompressed) decompressor
are needed to see this picture.
Wang (2007) Cell Stem Cell 1:497-501
![Page 33: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/33.jpg)
Are Cancer Stem Cells Necessarily Rare?
![Page 34: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/34.jpg)
Somervaille and Cleary (2006) Cancer Cell 10:257-268
LSCs are frequent in mice with MLL-AF9 leukemia
![Page 35: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/35.jpg)
Kelly et al. (2007) Science 317:337
Tumor growth need not be driven by rare cancer stem cells
![Page 36: Cancer Stem Cells](https://reader033.fdocuments.in/reader033/viewer/2022052312/577cc7a01a28aba711a18098/html5/thumbnails/36.jpg)
Bottom line…
Cancers may contain cells with some capacity to self-renew and produce multiple transformed cell types (TICs or CSCs). Not necessarily transformed stem cells… These may represent important targets for future therapies…
Genetic instability inherent to cancer cells generates mutations that can be selected during treatment, resulting in more resistant form of the disease…
Successful treatment of cancer - transforming it from a fatal to a chronic disease - will require a combination of different treatments tailored to each cancer as it develops. Some will target common features, some individual ones…
The challenge - how do we identify the critical Achilles’ heel for a given tumor (given the large number of mutations, some of which are important, some perhaps not…), and how do we treat it without killing normal cells…?